Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual)
N/A
The purpose of the PAUSE-Virtual Study is to show that by changing pre-surg...
Status
Recruiting
Location
Endeavor Health - Northshore
Start Date
2021-12-01
Trial ID
NCT06844227
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
NA
PAUSE 2 study is a prospective, open-label, blinded-endpoint non-inferiorit...
Perioperative Anticoagulant Use for Surgery Evaluation Emergency Registry
N/A
Among patients who are receiving long-term anticoagulant therapy, whether w...
Status
Completed
Location
Hamilton General Hospital
Start Date
2019-08-07
Trial ID
NCT04195113
Peri-procedural Management of Direct Oral Anticoagulants for Central VENOus Catheters in CAncer Patients With Venous Thromboembolism or Atrial Fibrillation Pilot Study
NA
The peri-procedural management of direct oral anticoagulants (DOACs) in per...
Perioperative Anticoagulant Use for Surgery Evaluation Study
N/A
The aim of the Perioperative Anticoagulant Use for Surgery Evaluation (PAUS...
Status
Completed
Location
Department of Pharmacy, Kaiser Permanente Colorado, Aurora, CO, USA
Start Date
2014-08-01
Trial ID
NCT02228798
Comparison Between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary Intervention
NA
A prospective, multicenter, 1:1 randomized, investigator initiated study. G...